Daratumumab/hyaluronidase Interactions
There are 233 drugs known to interact with daratumumab/hyaluronidase, along with 2 disease interactions. Of the total drug interactions, 46 are major, 121 are moderate, and 66 are minor.
- View all 233 medications that may interact with daratumumab/hyaluronidase
- View daratumumab/hyaluronidase disease interactions (2)
Most frequently checked interactions
View interaction reports for daratumumab / hyaluronidase and the medicines listed below.
- Adderall XR (amphetamine / dextroamphetamine)
- Ambien (zolpidem)
- Aranesp (darbepoetin alfa)
- Aspir 81 (aspirin)
- Aspirin Low Strength (aspirin)
- Ativan (lorazepam)
- Banophen (diphenhydramine)
- Belbuca (buprenorphine)
- Benadryl (diphenhydramine)
- Benadryl Allergy (diphenhydramine)
- Breo Ellipta (fluticasone / vilanterol)
- Calcium 600 D (calcium / vitamin d)
- Coenzyme Q10 (ubiquinone)
- Colace (docusate)
- Compazine (prochlorperazine)
- Cytoxan (cyclophosphamide)
- Decadron (dexamethasone)
- Eliquis (apixaban)
- Emgality (galcanezumab)
- Excedrin Tension Headache (acetaminophen / caffeine)
- FiberCon (polycarbophil)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flexeril (cyclobenzaprine)
- Flomax (tamsulosin)
- Kyprolis (carfilzomib)
- Metoprolol Succinate ER (metoprolol)
- Revlimid (lenalidomide)
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
Daratumumab/hyaluronidase disease interactions
There are 2 disease interactions with daratumumab / hyaluronidase which include:
More about daratumumab / hyaluronidase
- daratumumab/hyaluronidase consumer information
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: CD38 monoclonal antibodies
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.